<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The marked increases in p53 and p21/WAF1 levels that occur during Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and the generation of immortal B lymphoblastoid cell lines (LCL) do not lead to <z:mpath ids='MPATH_73'>growth arrest</z:mpath> or <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, although increasing <z:mp ids='MP_0002169'>wild-type</z:mp> (wt) p53 levels in EBV-infected cells by transfection or DNA damage induce these effects </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that the concentration of p53 relative to that of LMP1 determines whether EBV-infected B cells undergo <z:mpath ids='MPATH_73'>growth arrest</z:mpath> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Cell cycle arrest and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> were evaluated in LCL expressing varying p53 levels achieved by treating the cells with increasing concentrations of <z:chebi fb="2" ids="27899">cisplatin</z:chebi>, and we supplemented this approach with experiments in EBV-infected Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells transfected with a temperature-sensitive (ts) mutant human p53 and studies in LCL infected with recombinant adenoviruses expressing wt and ts mutant p53 </plain></SENT>
<SENT sid="3" pm="."><plain>Small increases in p53 and p21/WAF1 led to cell cycle arrest at the G2/M boundary, but not to <z:mpath ids='MPATH_3'>apoptosis</z:mpath>; moderate increases resulted in <z:mpath ids='MPATH_73'>growth arrest</z:mpath> at the G1/S boundary, also without <z:mpath ids='MPATH_3'>apoptosis</z:mpath>; and large increases also induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>These results confirm the hypothesis and reveal unanticipated complexities in cell cycle regulation by p53 </plain></SENT>
</text></document>